Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001856241 | SCV002236674 | pathogenic | Charcot-Marie-Tooth Neuropathy X | 2021-11-06 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the GJB1 protein in which other variant(s) (p.Arg220*) have been determined to be pathogenic (PMID: 7477983, 8162049, 9364054, 21291455). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 637620). This premature translational stop signal has been observed in individual(s) with Charcot-Marie-Tooth (CMT) disease (PMID: 21291455). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Val152Serfs*44) in the GJB1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 132 amino acid(s) of the GJB1 protein. |
Inherited Neuropathy Consortium | RCV000789882 | SCV000929267 | uncertain significance | Charcot-Marie-Tooth disease | no assertion criteria provided | literature only | ||
Inherited Neuropathy Consortium Ii, |
RCV003447285 | SCV004174659 | uncertain significance | Charcot-Marie-Tooth disease X-linked dominant 1 | 2016-01-06 | no assertion criteria provided | literature only |